Sutro Biopharma (NASDAQ: STRO)
$3.70
(-2.5%)
-$0.10
Price as of April 18, 2024, 11:47 a.m. ET
Sutro Biopharma Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Sutro Biopharma Company Info
Sutro Biopharma Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.
News & Analysis
Featured Article
Why Sutro Biopharma Stock Is Losing Ground Today
Phase 1 data for its ovarian cancer candidate was a little disappointing.
Cory Renauer | Jan 6, 2022
Featured Article
Why Sutro Biopharma Blasted 33% Higher on Friday
One of the company's pipeline treatments shows encouraging results in ovarian cancer patients.
Eric Volkman | Dec 4, 2020
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.